Marc Gewillig
16 posts


aepc.org/news/the-impli…
MDR in Europe: we expect the treatment of newborns, babies and children with congenital heart disease to significantly regress in Europe by 2024 due to lack or shortage of specialized medical devices, despite their good performance over the last decades.
English

Always a pleasure to listen to @MarcGewillig. Hausdorf lecture #AEPC2022. Thinking outside the 📦 and leaving behind the cardiocentric view 👇 @Cardio_KULeuven @KU_Leuven @EctorJoris @WernerBudts @saramoscatelli7

English
Marc Gewillig retweetledi

Excellent thread by @ralogon on the most recent article from the 🇦🇺 and 🇳🇿 #Fontan registry. @WernerBudts @MarcGewillig
Rafa Alonso@ralogon
Data from the Australia & NZ registry (1703 patients): jacc.org/doi/10.1016/j.… Open thread👇#ACHD #Fontan
English
Marc Gewillig retweetledi

Dr Marc Gewillig gave a brilliant talk on Fontan failure. Highlighted the role of the circulation rather than the heart itself.... In failure..... Asked to pay attention to fine tuning the circulation from the very beginning. #pcsi2019 #FONTAN @MarcGewillig

English
Marc Gewillig retweetledi

Congrats, @alexvdbruaene , @MarcGewillig and colleagues! #CongenitalHeartDisease #Fontan #TCPC #CavoPulmonaryConnection researchgate.net/publication/33…
English
Marc Gewillig retweetledi

Early bird registration #EuroGuch2020 until Jan 31st. #ACHD meeting in #Leuven! Register timely! kuleuvencongres.be/euroguch2020
@alexvdbruaene @AlexFrogoudaki @MarcGewillig @escardio @Mag_Ladouceur @judback
@MoonsPhilip @euroguch #AEPC #ISACHD

English

Clinicians caring for Fontan patients are “frustrated” when attempting to influence the Fontan circuit: classic cardiac algorithms which are very successful in many diseases can apparently not be extrapolated to the Fontan circuit. Why ?
Read this: researchgate.net/publication/33…
English











